- Home
- JXJT vs OGEN Comparison
JXJT vs OGEN Comparison
Compare JXJT & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXJT
- OGEN
- Stock Information
- Founded
- JXJT 2012
- OGEN 1996
- Country
- JXJT China
- OGEN United States
- Employees
- JXJT N/A
- OGEN N/A
- Industry
- JXJT Apparel
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- JXJT Consumer Staples
- OGEN Health Care
- Exchange
- JXJT Nasdaq
- OGEN Nasdaq
- Market Cap
- JXJT 11.5M
- OGEN 4.5M
- IPO Year
- JXJT 2012
- OGEN N/A
- Fundamental
- Price
- JXJT $1.57
- OGEN $0.34
- Analyst Decision
- JXJT
- OGEN
- Analyst Count
- JXJT 0
- OGEN 0
- Target Price
- JXJT N/A
- OGEN N/A
- AVG Volume (30 Days)
- JXJT 36.7K
- OGEN 389.1K
- Earning Date
- JXJT 11-01-2024
- OGEN 11-07-2024
- Dividend Yield
- JXJT N/A
- OGEN N/A
- EPS Growth
- JXJT N/A
- OGEN N/A
- EPS
- JXJT 0.48
- OGEN N/A
- Revenue
- JXJT $31,840,588.00
- OGEN $7,466.00
- Revenue This Year
- JXJT N/A
- OGEN N/A
- Revenue Next Year
- JXJT N/A
- OGEN N/A
- P/E Ratio
- JXJT $3.40
- OGEN N/A
- Revenue Growth
- JXJT N/A
- OGEN N/A
- 52 Week Low
- JXJT $1.04
- OGEN $0.29
- 52 Week High
- JXJT $8.51
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- JXJT 38.73
- OGEN 37.15
- Support Level
- JXJT $1.40
- OGEN $0.29
- Resistance Level
- JXJT $1.75
- OGEN $0.45
- Average True Range (ATR)
- JXJT 0.14
- OGEN 0.04
- MACD
- JXJT -0.04
- OGEN 0.02
- Stochastic Oscillator
- JXJT 32.08
- OGEN 28.88
About JXJT JX Luxventure Limited
JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.